174 related articles for article (PubMed ID: 30359406)
1. Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors.
Rupniak NMJ; Perdona E; Griffante C; Cavallini P; Sava A; Ricca DJ; Thor KB; Burgard EC; Corsi M
PLoS One; 2018; 13(10):e0205894. PubMed ID: 30359406
[TBL] [Abstract][Full Text] [Related]
2. Potency, efficacy, and selectivity of GR64349 at human recombinant neurokinin NK2 and NK1 receptors.
Perdona E; Cavallini P; Sava A; Griffante C; Ricca DJ; Thor KB; Rupniak NMJ; Corsi M
Neurosci Lett; 2019 Oct; 711():134456. PubMed ID: 31445972
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of a novel, selective radioligand, [125I][Lys5,Tyr(I2)7,MeLeu9,Nle10]neurokinin A-(4-10), for the tachykinin NK2 receptor in rat fundus.
Burcher E; Badgery-Parker T; Zeng XP; Lavielle S
Eur J Pharmacol; 1993 Mar; 233(2-3):201-7. PubMed ID: 8385622
[TBL] [Abstract][Full Text] [Related]
5. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
6. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10).
Zeng XP; Lavielle S; Burcher E
Neuropeptides; 1994 Jan; 26(1):1-9. PubMed ID: 7512696
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
Warner FJ; Comis A; Miller RC; Burcher E
Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
[TBL] [Abstract][Full Text] [Related]
8. Independent coupling of the human tachykinin NK2 receptor to phospholipases C and A2 in transfected Chinese hamster ovary cells.
Catalioto RM; Cucchi P; Renzetti AR; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):395-403. PubMed ID: 9826060
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A.
Comis A; Burcher E
J Pept Res; 1999 Mar; 53(3):337-42. PubMed ID: 10231723
[TBL] [Abstract][Full Text] [Related]
10. [125I]His-neurokinin A binds selectively to NK2 receptors of the B-type in rat small intestine smooth muscle membranes.
Brown MC; Biagi M; Renzetti AR; Rovero P; Criscuoli M; Mizrahi J
Eur J Pharmacol; 1992 Oct; 227(2):163-71. PubMed ID: 1330648
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tachykinin NK2 receptors in human urinary bladder.
Zeng XP; Moore KH; Burcher E
J Urol; 1995 May; 153(5):1688-92. PubMed ID: 7715011
[TBL] [Abstract][Full Text] [Related]
12. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
13. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
14. A single mutation of the neurokinin-2 (NK2) receptor prevents agonist-induced desensitization. Divergent conformational requirements for NK2 receptor signaling and agonist-induced desensitization in Xenopus oocytes.
Nemeth K; Chollet A
J Biol Chem; 1995 Nov; 270(46):27601-5. PubMed ID: 7499223
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
16. Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colon.
Warner FJ; Liu L; Lubowski DZ; Burcher E
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):928-33. PubMed ID: 11071312
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line.
Subramanian N; Ruesch C; Bertrand C
Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607
[TBL] [Abstract][Full Text] [Related]
18. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
19. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.
Foulon DM; Champion E; Masson P; Rodger IW; Jones TR
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):915-21. PubMed ID: 7692776
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
